Author

V. A. Ngo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:biophysical modeling· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Approach:simulation· 1 Assay:structural biology· 1

Frequent Co-Authors

C. E. Clancy· 1 shared I. Vorobyov· 1 shared J. R. D. Dawson· 1 shared K. R. DeMarco· 1 shared P.-C. Yang· 1 shared R. K. Jha· 1 shared S. Bekker· 1 shared S. Y. Noskov· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

C. E. Clancy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identifying Key Determinants of SARS-CoV-2/ACE2 Tight Interaction

V. A. Ngo, R. K. Jha

This study identifies key residues in SARS-CoV-2 RBD that enhance binding to ACE2 compared to SARS-CoV through long simulations and force field comparisons.

PLOS ONE · Sep 28, 2021Peer-reviewedBiophysics

Atomistic modeling towards predictive cardiotoxicity

K. R. DeMarco, J. R. D. Dawson, P.-C. Yang, S. Bekker, V. A. Ngo, S. Y. Noskov, V. Yarov-Yarovoy, C. E. Clancy, I. Vorobyov

This paper develops a computational framework to distinguish safe and unsafe hERG blockers by modeling atomic interactions and simulating drug-channel dynamics.

bioRxiv · May 11, 2019 · PreprintBiophysics